Drugs Made In America Acquisition (DMAAR) Long-Term Debt Issuances (2025)
Drugs Made In America Acquisition (DMAAR) posted Long-Term Debt Issuances of $900000.0 for Q1 2025.
Drugs Made In America Acquisition (DMAAR) Long-Term Debt Issuances (2025) Analysis & Trends
Drugs Made In America Acquisition's Long-Term Debt Issuances history runs 1 years deep, the most recent figure standing at $900000.0 for Q1 2025.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $900000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $900000.0 (changed N/A YoY) and the FY2025 annual result came in at $900000.0, down 30.79% from the prior year.
- Long-Term Debt Issuances was $900000.0 for Q1 2025 at Drugs Made In America Acquisition.
- Across five years, Long-Term Debt Issuances topped out at $900000.0 in Q1 2025 and bottomed at $900000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | SIM Acquisition Corp. I | 314.52 Mn | 314.52 Mn | - | 702,262.00 |
| 2 | Thayer Ventures Acquisition | 208.29 Mn | 208.29 Mn | - | -1.50 Mn |
| 3 | Newbury Street II Acquisition | 185.26 Mn | 185.26 Mn | - | - |
| 4 | Dynamix | 179.36 Mn | 179.36 Mn | - | - |
| 5 | Hallmark Venture | 103.01 Mn | 102.76 Mn | - | 57,641.00 |
| 6 | Voyager Acquisition | 99.58 Mn | 99.45 Mn | - | - |
| 7 | Gores Holdings X | 95.80 Mn | 95.37 Mn | - | - |
| 8 | Archimedes Tech SPAC Partners | 89.54 Mn | 89.54 Mn | - | 249,073.00 |
| 9 | Marblegate Capital | 81.65 Mn | 55.81 Mn | - | - |
| 10 | Drugs Made In America Acquisition | 1.39 Mn | 1.39 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 900,000.00 |
| Mar 31, 2025 | 900,000.00 |